Generic script share and the price of brand-name drugs: the role of consumer choice

@article{Rizzo2008GenericSS,
  title={Generic script share and the price of brand-name drugs: the role of consumer choice},
  author={John A. Rizzo and Richard J Zeckhauser},
  journal={International Journal of Health Care Finance and Economics},
  year={2008},
  volume={9},
  pages={291-316}
}
Pharmaceutical expenditures have grown rapidly in recent decades, and now total nearly 10% of health care costs. Generic drug utilization has risen substantially alongside, from 19% of scripts in 1984 to 47% in 2001, thus tempering expenditure growth through significant direct dollar savings. However, generic drugs may lead to indirect savings as well if their use reduces the average price of those brand-name drugs that are still purchased. Prior work indicates that brand-name producers do not… CONTINUE READING
BETA

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 16 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 23 REFERENCES

Prescription drug trends

  • Kaiser Family Foundation.
  • Washington, DC: Kaiser Family Foundation.
  • 2004

Prescription drugs: A vital component of health care

  • Center on an Aging Society.
  • Washington, DC: Georgetown University.
  • 2002

The FTC’s Pharmaceutical Industry Cases.

  • M. H. Meier
  • California Bar Association
  • 2002
1 Excerpt

A century of progress

  • Pharmaceutical Research, Manufacturers of America.
  • Washington, DC: Pharmaceutical Research and…
  • 2001

Similar Papers

Loading similar papers…